INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 11/20/2024 at 22:00, 1 year 2 months ago

Combined General Meeting of December 11, 2024 - Availability of the preparatory documents
Inventiva announces availability of preparatory documents for Combined General Meeting on December 11, 2024. Shareholders can participate in person or request documents electronically. Detailed resolutions and meeting information provided

Shareholders Resolutions Preparatory Documents Combined General Meeting Inventiva
BRIEF

published on 11/15/2024 at 22:05, 1 year 2 months ago

Inventiva Reveals Promising Phase 2 Study Results of Lanifibranor and Empagliflozin Combination

Phase 2 Study Clinical Trial Results Inventiva Lanifibranor MASH And T2D
PRESS RELEASE

published on 11/15/2024 at 22:00, 1 year 2 months ago

Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
Inventiva presents positive results from Phase 2 study on lanifibranor and empagliflozin combination therapy for MASH and T2D patients at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor Empagliflozin T2D
BRIEF

published on 10/30/2024 at 21:05, 1 year 3 months ago

Inventiva's Stock Rises Following Positive Update on Lanifibranor Trial

Inventiva MASH Lanifibranor NATiV3 Clinical Trial DMC Recommendation
PRESS RELEASE

published on 10/30/2024 at 21:00, 1 year 3 months ago

Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
Inventiva receives positive recommendation from fifth DMC review for lanifibranor in MASH Phase 3 trial, confirming good safety profile

Safety Data Inventiva MASH Lanifibranor Positive Recommendation
BRIEF

published on 10/23/2024 at 11:38, 1 year 3 months ago

Invus Public Equities exceeds thresholds at Inventiva

Voting Rights Capital Increase Crossing Thresholds Inventiva Invus Public Equities
BRIEF

published on 10/23/2024 at 11:36, 1 year 3 months ago

BVF Partners Crosses Thresholds in Inventiva's Capital

Voting Rights Capital Increase Crossing Thresholds Inventiva BVF Partners
BRIEF

published on 10/21/2024 at 14:35, 1 year 3 months ago

Inventiva presents an abstract at the Liver Meeting™ 2024

Clinical Trial Inventiva NASH Lanifibranor Liver Meeting™
PRESS RELEASE

published on 10/21/2024 at 14:30, 1 year 3 months ago

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
BRIEF

published on 10/14/2024 at 19:50, 1 year 3 months ago

Inventiva obtains AMF approval for its financing prospectus

AMF Funding Inventiva Steatohepatitis Drugs

Accesswire

Published on 02/07/2026 at 01:00, 1 day 10 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 12 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 13 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 20 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 22 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 14 hours 30 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 18 hours 55 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 19 hours 10 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 16 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 17 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 17 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 19 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 16 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 17 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 17 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE